Dare Bioscience Inc (DARE)

[benandemmiboo]

The reverse split happened in the process of Cerulean selling off their assets, and their ticker essentially being acquired by DARE, which had been a private company. This last financing was DARE's first as a public company; it had been using monies used from Cerulean with the drugs that Cerulean had sold to other companies.
I think it's likely their business model will have them do a financing after each time they acquire the licensing of a new product, and that they'll always raise enough money to get them to an inflection point with that drug -- should we sell it; should we take it through FDA approval, etc? -- but I really do not see reverse splits or anything like that being a concern. They have close connections with non-profits, etc, and the concern for me is less that they are spend-happy (they're not) but that they are not as profit-motivated as they could be.
Then again, their CEO has a mostly business background.